CURRICULUM VITAE - GLEN N. BARBER
PRESENT ADDRESS / PHONE:
Department of Medicine
and Sylvester Comprehensive Cancer Center
The University of Miami School of Medicine
Rm 511, Papanicolaou Building
1550 NW 10th Ave [M877]
Tel (305) 243 5914
Fax (305) 243 5885
e-mail gbarber@med.miami.edu
BIRTH DATE / PLACE:
June 23, 1962 / Hartlepool, Great Britain
CITIZENSHIP:
United Kingdom
EDUCATION:
B. Sc. 1984
Ph.D. 1988
Honours Degree, Molecular Biology/Biophysics.
Biophysics Laboratories, University of Portsmouth, Hampshire,
England (1981-84)
Center for Applied Microbiology and Research (CAMR); Porton
Down, Salisbury, Wiltshire, and The London School of Hygiene
and Tropical Medicine, London University (1985-88)
RESEARCH and PROFESSIONAL EXPERIENCE:
2006-
Eugenia J. Dodson Chair in Cancer Research,
Sylvester Comprehensive Cancer Center (SCCC), University of Miami
Miller School of Medicine (UMMSM), Miami, FL, USA.
2006-
Associate Director for Basic Research, SCCC, UMMSM.
2008-
Professor, Department of Medicine; UMMSM.
2004-2008
Professor, Department of Microbiology and Immunology; UMMSM.
1999-2004
Associate Professor, Department of Microbiology and Immunology,
UMMSM..
1995-1998
Assistant Professor, Department of Microbiology and Immunology,
Winship Cancer Center, Emory University, Atlanta GA, USA.
1995
Visiting Scientist, The Institute of Medical Science, The
University of Tokyo, Minato-ku, Tokyo, Japan.
1993-1995
Research Assistant Professor, Department of Microbiology,
University of Washington, Seattle, WA USA.
1989-1993
Research Associate, Regional Primate Research Center and
Department of Microbiology, University of Washington, Seattle, WA.
PUBLICATIONS:
1. Clegg J.C.S., Barber G.N., Chamberlain J. and Oram J. (1986) Expression of Lassa virus
nucleocapsid gene fragments in bacteria. Med Microbiol 175: 93-95.
2. Barber G.N., Clegg J.C.S and Chamberlain J. (1987) Expression of Lassa virus nucleocapsid
protein segments in bacteria: purification of high level expression products and their
application to antibody detection. Gene 56: 137-144.
3. Lloyd G., Barber G.N., Clegg J.C.S. and Kelly P. (1989) Identification of Lassa fever virus
infection with recombinant nucleocapsid protein antigen. Lancet Nov 89: 1222
4. Barber G.N., Clegg J.C.S. and Lloyd G. (1990) Expression of the Lassa virus nucelocapsid
protein in cells infected with a recombinant baculovirus: application to diagnostic assays for
Lassa virus infection. J Gen Virol 71: 19-28
5. Barber, G.N., Tomita, J., Hovanessian, A.G., Meurs, E. and Katze, M.G. (1991) Functional
expression and characterization of the interferon-induced dsRNA activated P68 protein
kinase from Escherichia coli. Biochem 30:10356-10361
6. Katze M.G., Wambach M., Meurs E., Hovanessian A.G., Garfinkel M. and Barber G.N.
(1991) Functional expression and RNA binding analysis of the interferon-induced, dsRNA
activated 68,000 Mr protein kinase in a cell-free system. Mol Cell Biol. 11:5497-5505
7. Hu, S-L., Abrams K., Barber G.N., Moran P., Zarling J.M., Morton W.R., Kuller L. and
Benveniste R.E. (1992) Protection of macaques against homologous SIV infection by
immunization with recombinant made SIVMne gp160. Science 255:456-459
8. Meurs E., Watanabe Y., Kadereit S., Barber G.N., Katze M.G, Chong K., Williams B.R.G.,
Hovanessian AG (1992) Constitutive expression of human dsRNA activated p68 kinase in
murine cells mediates phosphorylation of eIF2 and partial resistance to EMC virus growth.
J Virol. 66:5805-5814
9. Koromilas A.E., Roy S., Barber G.N., Katze M.G. and Sonenberg N. (1992) Malignant
transformation by a mutant of the interferon inducible dsRNA dependent kinase. Science
257:1597-1832
10. Barber G.N., Tomita J, Hovanessian A.G, Meurs E, Katze M.G. (1992) Detection of protein
kinase homologues and viral RNA binding domains utilizing polyclonal antiserum prepared
against a baculovirus expressed dsRNA activated 68,000 dalton protein kinase. Virology.
191:670-679
11. Meurs E., Galabru J., Barber G.N., Katze M.G., Hovanessian A.G. (1993) Tumour
suppressor function of the interferon-induced 68 kDa protein kinase Proc Natl Acad Sci
(USA) 90:232-236.
12. Black T.L, Barber G.N., Katze M.G. (1993) Degradation of the Interferon induced 68,000
Mr protein kinase by poliovirus requires RNA. J. Virol. 67:791-800
13. Dever T.E., Chen J.J., Barber G.N., Cigan A.M., Feng L., Donahue T.F., London I., Katze
M.G. and Hinnebusch A. (1993) Mammalian eIF-2 alpha kinases functionally substitute for
GCN2 and stimulate GCN4 translation in yeast. Proc Natl Acad Sci (USA) 90:4616-4620.
14. Barber G.N., Wambach M., Wong M-L., Dever T.E., Hinnebusch A., and Katze M.G.
(1993) Translational regulation by the interferon-induced dsRNA-activated 68kDa protein
kinase. Proc Natl Acad Sci (USA) 90:4621-4625.
15. Barber G.N., Edelhoff S., Katze M.G., and Disteche C.(1993) Assignment of the interferoninducible double-stranded RNA-dependent protein kinase to human chromosome 2P21 and
mouse chromosome 17E2. Genomics. 16:765-767.
16. Hu S-L., Stallard V., Abrams K., Barber G.N., Kuller L., Langlois A.J., Morton W.R., and
Benveniste R.E. (1993) Protection of vaccinia-primed macaques against SIVmne infection by
combination immunization with recombinant vaccinia virus and SIVmne gp160. J. Med.
Prim. 22:92-100.
17. Barber G.N., Thompson S, Lee T.-G., Strom T., Daveau A., Katze M.G. (1994) The 58KDa
inhibitor of the interferon-induced dsRNA activated protein kinase (PKR) is a TPR protein
with oncogenic properties. Proc Natl Acad Sci (USA) 91:4278-4282.
18. Romano PR, Green SR, Barber GN, Mathews MB, Hinnebusch AG. (1995) Structural
requirements for dsRNA-binding, dimerization and activation of the human eIF-2 alpha
kinase DAI in yeast. Mol. Cell. Biol. 15:365-378.
19. Rajan P, Swaminathan S, Zhu J, Cole CN, Barber GN, Tevethia MJ, Thimapaya B. (1995)
A novel translational regulation function for the Simian Virus large-T antigen gene. J. of
Virol. 69:785-795.
20. Barber G.N., Katze M.G., Jagus R. (1995) Molecular Mechanisms responsible for malignant
transformation by regulatory and catalytic domain variants of the interferon-induced enzyme
PKR J.Biol. Chem. 270:17423-17428
21. Barber G.N., Wambach M, Thompson S, Jagus R, Katze MG (1995) PKR protein Kinase
mutants lacking dsRNA binding domain I can act as transdominant inhibitors and induce
malignant transformation. Mol. Cell. Biol. 15:3138-3146.
22. Polyack S., Tang N, Wambach M, Barber G.N. and Katze, M.G. (1996) The p58 cellular
inhibitor complexes with the IFN-induced, dsRNA-dependent protein kinase, PKR, to
regulate it’s autophosphorylation and activity. J. Biol. Chem., 271(3):1702-1707.
23. Sharp T, Moonan F., Romashko A., Barber G.N. and Jagus R. (1998) Comparative analysis
of the binding of vaccinia virus K3L and E3L gene products to PKR in vitro and in vivo.
Virology, 250; 302-315.
24. Abraham N, Jaramillo ML, Duncan PI, Méthot N, Icely PL, Barber G.N, Bell J.C. (1998)
The murine PKR tumor supressor gene rearranged in a lymphocytic leukaemia. Experimental
Cell Research. 244: 394-404.
25. Balachandran S. Kim C. N., Yeh W-C., Mak T.W., Bhalla K and Barber G.N. (1998)
Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADDmediated death signaling. The EMBO Journal. 17 (23), 6888-6902.
26. Taylor D., Shi S.T., Romano P., Barber G.N., Lai M. (1999) Inhibition of the interferoninducible protein kinase, PKR, by Hepatitis C virus E2 protein. Science. 285; 107-110.
27. Balachandran S., Roberts C., Compans R.W., Archer D., and Barber G.N. (2000) Interferon
potentiates viral induced apoptosis through activation of the FADD/caspase-8 death signaling
pathway. J. of Virol., 74; 1513-1523.
28. Heylbroek C., DeLuca C., Lin R., Balachandran S., Barber G.N., and Hiscott J. (2000) The
IRF-3 transcription factor is an essential mediator of virus induced apoptosis. J. of Virol., 74
3781-3792.
29. Balachandran S., Roberts C., Pattnaik V., Archer D and Barber G.N. (2000) Essential role
for the dsRNA-dependent protein kinase, PKR, in innate immunity to viral infection.
Immunity 13: 129-131.
30. Balachandran S. and Barber G.N. (2000). Vesicular Stomatitis Virus, VSV, therapy of
tumors. IUBMB Life 50 125-138.
31. Saunders L, Jurecic, V., and Barber G.N. (2001) The 90 and 110 kDa human NFAR
proteins are translated from two differentially spliced mRNAs encoded from chromosome
19p13. Genomics 71 (2).
32. Balachandran S, Porosnicu M and Barber G.N. (2001) The oncolytic activity of vesicular
stomatitis virus, VSV, is effective against tumors with aberrent p53, Ras or Myc expression
and involves the induction of apoptosis. J. of Virology 75, 3474-3479
33. Ezelle H., Balachandran S., Polyack S and Barber G.N. (2001). Analyzing the mechanisms
of interferon-induced apoptosis using CrmA and hepatitis virus NS5A. Virology 281, 124137.
34. Lin R., Genin P., Harrington W., Barber G.N. and Hiscott J. (2001) HHV-8 encoded vIRFs
interferes with the IFN antiviral response by blocking IRF-3 recruitment of CBP/p300
coactivators. Oncogene 15;20(7),800-11.
35. Polyack S.J., et al., (2001) A novel mechanism of hepatitis C virus interferon resistance:
Induction of expression of the CXC chemokine, IL-8, by non-strutural 5a protein. J. of Virol.
75(13), 6095-6106.
36. Saunders L., Balachanadran S., Michaels R.,
Ford R and Barber G.N (2001).
Characterization of two alternatively spliced nuclear phosphoproteins, NFAR-1 and 2 that
regulate mRNA processing and interact with the interferon-induced, dsRNA-dependent
protein kinase, PKR. J. of Biol Chem. 276 (34) 32300-32312.
37 Toomey N., Wood C., Deyev V., Boise L., Scott D., Liu L., Podack E., Barber G.N. and
Harrington W. (2001) The mechanism of interferon-targeted therapy against HHV-8
associated lymphoma involves the induction of TRAIL-mediated apoptosis. Oncogene 20(48)
7029-40.
38 Fernandez M., Porosnicu M., Markovic D and Barber G.N. (2002) Genetically engineered
Vesicular Stomatitis Virus in gene therapy: Application for the treatment of malignant
disease. J. of Virol. 76(2) 895-904.
39. Grandvaux N, Servant MJ., tenOever B., Sen G., Balachandran S., Barber G.N., Lin R., and
Hiscott J (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: Direct
involvement in the regulation of interferon stimulated genes. J. of Virol. 76(11) 5532-5539.
40 Pataer A., Vorburger S., Barber G.N., Chada S., Mhashilkar A., Zou-yang H., Balachandran
S., Roth J., Hunt K., and Swisher S. (2002) Adenoviral transfer of the melanoma
differentiation association gene (Ad-mda-7) induces apoptosis of lung cancer cells via
upregulation of the dsRNA-dependent protein kinase PKR. Cancer Research 62 2239-2243.
41. Vorburger SA., Pataer A, Yoshida K., Barber G.N. Ellis LM., Swisher SG and Hunt KK
(2002) Role for the dsRNA activated protein kinase, PKR, in E2F-1 induced apoptosis.
Oncogene 12(41); 6278-88.
42. Ezelle H., Markovic D and Barber G.N. (2002) Generation of hepatitis C virus-like particles
by use of a recombinant vesicular stomatitis virus vector J. of Virol. 76(23); 12325-34.
43. Ghosh SK., Wood C., Biose LH., Mian AM., Deyev VV, Feuer G., Toomey NL., Shank
NC., Cabral L., Barber GN. Harrington WJ. (2002) Potentiation of TRAIL-induced
apoptosis inprimary effusion lymphoma through AZT-mediated inhibition of NF-KB. Blood
15;101(6) 2321-7.
44. Ogilvie VC., Wilson BJ., Nicol SM., Saunders L.R., Barber GN. And Fuller-Pace F.V.
(2003) The highly related DEAD box helicases p68 and p72 exist as heterodimers in cells.
Nucleic Acid Research 1;31(5) 1470-80.
45. Obuchi M, Fernendez M and Barber G.N. (2003) Development of a recombinant vesicular
stomatitis virus that exploits defects in host defense, augments specific oncolytic activity J. of
Virol. 77(16):8843-56.
46. Porosnicu M and Barber G.N. (2003) Oncolytic efficacy of recombinant vesicular stomatitis
virus expressing cytosine deaminsase suicide cassette Cancer Research 63(23): 8366-76.
47. Balachandran S and Barber G.N. (2004) Defective translational control facilitates vesicular
stomatitis virus oncolysis. Cancer Cell 5(1): 51-65.
48. Perkins D.J and Barber G.N. (2004) Defects in translational regulation through
phosphorylation of eIF2 abrogates anti-viral activity and facilitates the malignant
transformation of human cells. Molecular and Cellular Biology 24(5) 2025-40.
49. Balachandran S, Thomas J and Barber G.N. (2004) A role for FADD in innate immune
signaling. Nature. 432; 401-405.
50. Faria-Waziry P, Cahraborty P, Levay A, Barber G.N. Ezelle H, Enninga J, Arana C, Van
Deursan J and Fontora B (2005) Viral disruption of the Nup98 and mrnp41/Rae1 mRNA
nuclear export pathway. Molecular Cell 17; 1-20.
51. Ghosh SK, Kurokawa M, Ramos JC, Mian AM, Toomey NL, Cabral L, Barber GN, Dittmer
D and Harrington WJ (2005) AZT inhibits NF-B and induces the Epstein-Barr virus lytic
program in Burkitt Lymphoma. Blood 106: 235-40.
52. Pataer A, Vorburger SA, Chada S, Balachandran S, Barber GN, Roth JA, Hunt KK and
Swisher SG (2005) Melanoma differenatiation associated gene-7 protein physically
associates with the dsRNA-dependent protein kinase, PKR. Mol Ther: 11(5)717-23.
53. Greidinger EL., Zang YJ, Jaimes K, Hogenmiller S., Nassiri M, Barber GN and Hoffman
RW (2006) A murine model of mixed connective tissue disease (MCTD) induced with U1snRNP autoantigen. Arthritis Rheum. 54(2):661-9.
54. Majid A., Shah S., Ezelle H and Barber G.N. (2006) Evaluating replication-defective
vesicular stomatitis virus as a vaccine vehicle. J. of Virol. 80(14):6993-7008.
55. Lin L., Su Z., Gupta P., Barber GN., Dent P, Sarkar D and Fisher PB (2006) Activation of
Ras/Raf protects cells from MDA-5 induced apoptosis. Cell Death and Differentiation
Nov;13(11):1982-93
56. Balachandran S, Venkataraman T, Fisher PB, Barber GN. (2007) Fas-associated death
domain-containing protein-mediated antiviral innate immune signaling involves the
regulation of IRF-7. J Immunol. Feb 15;178(4):2429-39.
57. Goodman AG., Smith JA., Balachandran S., Korth MJ., Barber GN, Schiff LA and Katze
MG (2007) P58, an eIF2 kinase inhibitor that is activated during viral infection and ER
stress regulates viral mRNA translation and replication. J Virol. Mar;81(5):2221-30.
58. Venkataraman, T., M. Valdes, S. Kakuta, G. Caceres, S. Saijo,Y. Iwakura and G. N. Barber.
DExD/H Box RNA Helicase LGP2 Exerts Disparate Function in Response to Infection by
RNA viruses. (2007) J. Immunol.15:178,6444-55
59. Radtke, A. L, Delbridge, L.M., Balachandran, S., Barber, G.N., and O’Riordan, M. X. D.
(2007) Interferon-ientndepend role for TBK1 in maintenance of vaculolar integrity during
intracellular bacterial infection. PLoS Pathogens 3(3) 29.
60. Greidinger EL, Zang Y, Martinez L, Jaimes K, Nassiri M, Bejarano P, Barber GN, Hoffman
RW. (2007) Differential tissue targeting of autoimmunity manifestations by autoantigenassociated Y RNAs. Arthritis Rheum. May;56(5):1589-97
61. Andrews NP., Pack CD., Vezys V., Barber GN and Lukacher AE (2007). Early virus
associated bystander events effects the fitness of the CD8 T cell response to persistent virus
infection. Journal of Immunology 178(11), 7276-75.
62. Diaz RM., Galvo F., Kottke T., Wongthida P., Qiao J., Thompson J., Valdez M., Barber
G.N and Vile RG. (2007) Oncolytic Immunotherapy for Melanoma using Vesicular
Stomatitis Virus. Cancer Research 15;67: 2840-8.
63 Sarkar D., Park ES., Barber GN. and Fisher PB (2007) Activation of dsRNA-dependent
protein kinase (PKR), a new pathway by which human polynucleotide phosphorylase
(hPNPase) induces apoptosis. Cancer Research 67(17):7948-53
64. Holzen UV., Raju U., Patear A., Vorburger SA., Roth JA., Barber GN., Hunt KK and
Swisher SG. (2007) The dsRNA-activated protein kinase (PKR) mediates radiation resistance
in mouse embryonic fibroblasts (MEFs) through NF-kB and AKT activation Clin Cancer
Res.13(20):6032-9
65. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM, Thompson J, Ryno P,
Barber GN, Chester J, Selby P, Harrington K, Melcher A, Vile RG. (2007) Purging
metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell
therapy, oncolytic virotherapy and immunotherapy. Nat Med. 2008 Jan;14(1):37-44.
66. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink
JR, Yewdell JW. (2008) Direct priming of antiviral CD8(+) T cells in the peripheral
interfollicular region of lymph nodes. Nat Immunol. 2008 Jan 13;
67. Pfeifer I, Elsby R, Fernandez M., Fontoura BM., Nussenzeig DR, Martin WD and Barber
GN (2008) The NFARs retain nuclear mRNA and control translation. (Proc Natl Acad Sci
(USA) in press.
68. Boutros R., Valova V., Nelson A., Barber GN., Robinson PJ and Byrne JA (2007)
Identification of NFAR-1 and vimentin as a novel TPD52L1 (d53)-associated protein through
large scale co-immunoprecipitation (Submitted).
69. Elsby R., Reid P., Kimball SR., Pavitt GD and Barber GN (2007) The alpha subunit of
eIF2B is requisite for eIF2-mediated translational suppression of VSV. (Submitted).
Review Articles. Book Chapters:
70. Barber G.N., Agy, M.B. and Katze, M.G. (1994) Regulation of viral and cellular gene
expression in cells infected by animal viruses including influenza virus and human
immunodeficiency virus type 1. Methods in Molecular Genetics: Molecular Virology, Vol 4.
Part A, Chapter 12 Academic Press.
71. Jagus R., Joshi B and Barber G.N. (1999) PKR, Apoptosis and Cancer: Translational control
and cancer. Int. J. of Biochemistry and Cell Biology. 31; 123-138.
72. Barber G.N. (2000) The Interferons and Cell Death: Guardians of the cell or accomplices
of apoptosis? Seminars in Cancer Biology Vol 10; 2 103-113.
73. Barber G.N. (2001) Host defense, Viruses and Apoptosis. Cell Death and and
Differentiation, Vol 8(2) 113-26.
74. Saunders L.R and Barber G.N. (2003) The dsRNA-binding protein family: Critical roles,
diverse cellular functions. FASEB J. 17(9):961-83.
75. Barber G.N. (2004) Vesicular stomatitis virus as an oncolytic vector. Viral Immunology
17(4); 516-27.
76. Barber G.N. (2005) Vesicular stomatitis virus and RNA-viruses as gene therapy vectors
(Cancer Drug Discovery and Development; Gene Therapy for Cancer; Edited by P. Dolgert,
Humana Press Inc [In Press]).
77. Balachandran S and Barber G.N. (2005) Interferon and Host Defense. Cancer Genomics and
Proteomics: Methods and Protocols. (Edited by P.B. Fisher, Humana Press Inc [In Press]).
78. Barber G.N. (2005) Interferon, PKR and Apoptosis. Cell Death and Differentiation
12(6)563-70.
79. Barber G.N (2005) VSV-selective replication and protein translation Oncogene
21;24(52):7710-9.
80. Majid A and Barber GN (2007) VSV as a vector for HCV vaccines (in press).
INTERNATIONAL FELLOWSHIPS AND AWARDS:
Instituto Juan March de Estudios e Investigaciones Fellowship (Spain;1993)
Japanese Society for the Promotion of Science (JSPS) Long Term Invitation Fellowship
(Japan: 1995)
International Society for Interferon and Cytokine Research (ISICR)
(Geneva 1996)
Sylvester Comprehensive Cancer Center Endowed Chair, 2003-present.
Sylvester Comprehensive Cancer Outstanding Investigator, 2005
GRANTS
ACTIVE:
1.) RO1 CA86431-07. 2004-2009; $1,900,000.
PI; Role of PKR in Growth Regulation and Apoptosis.
2.) RO1 CA095924- 03 2003-2008; $1, 800,000.
PI; Mechanisms of VSV-mediated Oncolysis.
3.) RO1 AI053670-03 2003-2008 $1,500,000.
PI; Evaluation of the immunogenicity of HCV-like particles.
4.) R21 AI077093 2008-2010 $500,000.
PI; Characterization of a novel helicase in innate immunity.
5.) Pre-SPORE Florida (Harrington): 2007-2009 $1,000,000.
PI Barber, 3rd project: VSV Oncolysis and Lymphoma.
6.) Susan G. Komen Breast Cancer Foundation 2005-2008
Mentor for Post-Doc ($100,000).
PENDING:
1.) RO1: (Barber), 2007. PI: Mechanisms of Innate Immunity. Score: 143
2.) PO1(Barber): 2007. PI: Innate immune regulation in viro-proliferative disease. Score 181.
JOURNAL REVIEWER:
Nature
Cancer Research (Ed Board).
Cell
Genetics.
Nature (Biotechnology).
Nucleic Acids Research
Oncogene
Int. J. Cancer Research
Gene
EMBO J.
Journal of Biological Chemistry
Journal of Virology.
Journal of Interferon Research.
Proc. Natl. Acad. Sci. USA
Molecular Cancer (Ed. Board).
Virology.
Virus Research
Molecular and Cellular Biology.
AD HOC GRANT REVIEWER
American Cancer Society (ACS).
DOD Breast cancer August 2002
NIH: HCV infection and liver disease. 2000. NIAID PO1 Virology SS 2003
Canadian Institute of Health Research.
NCI-C Interferon PO1 SS 2003
Nat. Sci. Found. (NSF).
NIH: Virology SS June 2002, February 2003, 2004,.
NCI-C Gene Therapy PO1 SS 2004
NIH Experimental Virology SS, June 2004.
NCI-PO1 SS June 2007.
ACS SS June, 2006.
UNIVERSITY SERVICE AND TEACHING:
1991, 1993
1993
1994
1996-98
1999-
20032003200320042006-
Instructor/Lecturer Department of Pathobiology,
University of Washington, WA.
Lecturer: Department of Microbiology, Graduate seminars in Virology
University of Washington, WA.
Lecturer: School of Medicine, Medical student seminars in Virology
University of Washington, WA.
Member, Graduate Programs in Microbiology and Molecular Genetics
(MMG) and Genetics and Molecular Biology (GMB) , Emory University.
Graduate students- lectures on Viral Oncology. Medical Students- RNA
viruses including retroviruses/HIV, tumor viruses. Physician AssistantVirology.
Lectures, Grad course in Micro and Immuno; Univ. of Miami School of Medicine.
Virology; Advanced course in virology, Methods in Molecular Biology, Tumor
Biology, Undergrad Virology.
Director, Graduate Virology, Department of Microbiology and Immunology,
Univ. Miami School of Med.
Chair, Search committee Virology, Department of Microbiology and
Immunology, University of Miami School Med.
Co-Director; Viral Oncology Program, SCCC, Univ Miami School Med.
Promotion and Tenure Board. Univ Miami School Med.
Associate Director for Basic Research, SCCC, Univ Miami School Med.
POST DOCTORAL ASSOCIATES.
Ingrid Pfeifer, Paula Faria (Susan Komen Breast Cancer Award). Hiroki Ishikawa. Ai Harajima.
GRADUATE STUDENTS:
Jinhee Hyun. Josh Heiber.
GRADUATES, Ph.D, FROM LAB: Siddharth Balachandran, Laura Saunders, Jason
Emmanuel, Darren Perkins, Heather Ezelle. Rachel Elsby.
MENTORSHIP: Siddharth Balachandran PhD (graduate student, post-doc, Res Asst Professor1996-2007) Asst Prof Fox Chase Cancer Center. Juan Carlos Ramos MD (Damon Runyon
Cancer Research Foundation 2007-2009).